结果：神经胶质瘤细胞株u343表达死亡受体DR5, DR 5分布于细胞内细胞核的周围。
Results: The expression of death receptor 5 (DR5) was certificated in U343, DR5 appeared to be located in intracellular perinuclear compartment.
目的探讨死亡受体dr5在急性非淋巴细胞白血病(ANL L)细胞中的表达及其临床意义。
AIM to reveal the expression of death receptor 5 (DR5) in the cells of acute non lymphocyte leukemia (ANLL) and its clinical significance.
目的：构建人死亡受体5 (DR5)真核表达载体，转染NS - 1细胞，建立稳定转染的NS - 1细胞系。
Objective: to construct eukaryotic expression vector of human death receptor (DR5) and transfect NS-1 cells to establish stable NS-1 cell line.
免疫组化和流式细胞术检测肾脏TRAIL基因及其死亡受体DR 4、DR5的蛋白表达。
Immunohistochemistry and FCM were used to detect the expression of TRAIL and its death receptors (DR4 and DR5).
死亡受体在胰腺癌中高表达，可能在TRAIL诱导胰腺癌细胞凋亡的机制中发挥重要的作用。
High death receptor expression may play an important role in TRAIL inducing pancreatic carcinoma apoptosis.
死亡受体在胰腺癌中高表达，可能在TRAIL诱导胰腺癌细胞凋亡的机制中发挥重要的作用。
High death receptor expression may play an important role in TRAIL inducing pancreatic carcinoma apoptosis.
应用推荐